Trial Profile
Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2017
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 07 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 03 Jun 2013 Planned end date changed from 1 Jun 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov record.
- 08 Aug 2012 New trial record